You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 18, 2025

Details for Patent: 10,751,355


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,751,355
Title:Methods for treating pulmonary non-tuberculous mycobacterial infections
Abstract: Provided herein are methods for treating a pulmonary infection in a patient in need thereof, for example, a nontuberculous mycobacterial pulmonary infection for at least one treatment cycle. The method comprises administering to the lungs of the patient a pharmaceutical composition comprising a liposomal complexed aminoglycoside comprising a lipid component comprising electrically neutral lipids and an aminoglycoside. Administration comprises aerosolizing the pharmaceutical composition to provide an aerosolized pharmaceutical composition comprising a mixture of free aminoglycoside and liposomal complexed aminoglycoside, and administering the aerosolized pharmaceutical composition via a nebulizer to the lungs of the patient. The methods provided herein result in a change from baseline on the semi-quantitative scale for mycobacterial culture for a treated patient, and/or NTM culture conversion to negative during or after the administration period.
Inventor(s): Eagle; Gina (Morristown, NJ), Gupta; Renu (Moorestown, NJ)
Assignee: INSMED INCORPORATED (Bridgewater, NJ)
Application Number:16/263,648
Patent Claim Types:
see list of patent claims
Use; Composition; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,751,355

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope, claims, and the broader patent landscape in which it exists. This article will delve into the details of United States Patent 10,751,355, focusing on its scope, claims, and the context within the patent landscape.

Understanding the Patent

Patent Overview

United States Patent 10,751,355 is owned by Insmed Incorporated and is related to their product Amikacin Liposome Inhalation Suspension, also known as Arikayce®. This patent is part of a series of patents and patent applications that Insmed holds for this product[2].

Patent Expiration

The patent is set to expire on May 15, 2035, which is a critical date for understanding the patent's lifespan and potential impact on the market[2].

Scope of the Patent

Claims Analysis

The scope of a patent is largely defined by its claims. Claims are the specific descriptions of what the patent covers and are the legal boundaries of the invention. For Patent 10,751,355, the claims would typically include detailed descriptions of the composition, method of use, and any specific features or improvements related to Amikacin Liposome Inhalation Suspension.

To analyze the claims, one would need to review the patent document itself, focusing on the claim sections. The USPTO provides resources such as the Patent Claims Research Dataset, which can offer insights into claim structures and scope, although this specific dataset may not include patents granted after 2014[3].

Claim Types

Patents can have various types of claims, including independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. Understanding the hierarchy of claims is essential for determining the patent's scope.

Patent Landscape

Global Patent Family

The patent landscape includes not just the U.S. patent but also its counterparts in other jurisdictions. For Insmed's product, there are patents and patent applications in various foreign jurisdictions, which are part of the global patent family. Tools like the Global Dossier provided by the USPTO can help in identifying related applications and their status across different IP offices[1].

Prior Art and Citations

The Common Citation Document (CCD) is a valuable resource for understanding the prior art cited by different patent offices for the same invention. This helps in visualizing the global patent landscape and identifying potential overlaps or conflicts with other patents[1].

Competitor Patents

Analyzing competitor patents in the same field can provide insights into the competitive landscape. For instance, searching databases like PATENTSCOPE or the European Patent Office's esp@cenet can reveal similar inventions and their claims, helping to understand the market positioning of Patent 10,751,355[1][4].

Searching and Analyzing Patents

USPTO Resources

The USPTO offers several tools for searching and analyzing patents, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. This tool provides enhanced access to prior art and is crucial for conducting thorough patent searches[1][4].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs can provide additional resources and training in patent search techniques, which can be invaluable for detailed analysis of patents like 10,751,355[1].

International Databases

Searching international patent databases such as those provided by the European Patent Office, Japan Patent Office, and World Intellectual Property Organization (WIPO) can help in identifying global patent filings related to the same invention[1].

Economic and Strategic Implications

Market Impact

Understanding the scope and claims of Patent 10,751,355 can help Insmed and competitors assess the market impact. The patent's expiration date, for example, can influence strategic decisions regarding product development and licensing.

Licensing and Collaboration

The patent landscape can also inform licensing and collaboration strategies. Knowing the claims and scope of related patents can help companies navigate potential partnerships or licensing agreements.

Legal Considerations

Infringement and Litigation

The claims of Patent 10,751,355 define what would constitute infringement. Companies must carefully analyze these claims to avoid potential litigation and ensure their products do not infringe on Insmed's patent.

Office Actions and Examinations

Tools like the Patent Examination Data System (PEDS) and Office Action Indicators within the Global Dossier can provide insights into the examination history of the patent, including any office actions that may have been addressed during the patent application process[1].

Key Takeaways

  • Patent Scope: The scope of Patent 10,751,355 is defined by its claims, which outline the specific aspects of Amikacin Liposome Inhalation Suspension that are protected.
  • Global Landscape: The patent is part of a global patent family with counterparts in various jurisdictions.
  • Competitor Analysis: Analyzing competitor patents is crucial for understanding the competitive landscape.
  • Search Tools: Utilizing tools like the Patent Public Search, Global Dossier, and international databases is essential for thorough patent analysis.
  • Economic and Strategic Implications: Understanding the patent's scope and claims can influence market strategies, licensing, and collaboration decisions.
  • Legal Considerations: Careful analysis of claims is necessary to avoid infringement and potential litigation.

FAQs

Q: How can I search for patents related to a specific product like Amikacin Liposome Inhalation Suspension? A: You can use the USPTO's Patent Public Search tool or international databases like PATENTSCOPE to search for patents related to a specific product. Utilizing classification schemes like the Cooperative Patent Classification (CPC) can also help narrow down the search[1][4].

Q: What is the significance of the Global Dossier in patent searching? A: The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and access citation data and office actions[1].

Q: How do I determine the expiration date of a patent? A: The expiration date of a patent can be found in the patent document itself or through databases like the USPTO's Patent Public Search. For Patent 10,751,355, the expiration date is May 15, 2035[2].

Q: What are the different types of claims in a patent? A: Patents typically include independent claims and dependent claims. Independent claims define the invention, while dependent claims further limit the independent claims[3].

Q: How can I avoid infringing on an existing patent like 10,751,355? A: To avoid infringement, carefully analyze the claims of the patent and ensure that your product or process does not fall within the scope defined by those claims. Consulting with a patent attorney can also be beneficial[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Insmed - Program Patents: https://insmed.com/program-patents/
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Clemson University - Advanced Patent Searching: https://clemson.libguides.com/advanced_patent_searching

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,751,355

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Insmed Inc ARIKAYCE KIT amikacin sulfate SUSPENSION, LIPOSOMAL;INHALATION 207356-001 Sep 28, 2018 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATING MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE IN ADULTS AS PART OF A COMBINATION DRUG REGIMEN ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.